- Glucarpidase, Leucovorin, and Thymidine for High-Dose Methotrexate-Induced Renal Dysfunction: Clinical and Pharmacologic Factors Affecting Outcome
[作者:Widemann, BC; Balis, FM; Kim, A; Boron, M; Jayaprakash, N; Shalabi, A; O'Brien, M; Eby, M; Cole, DE; Murphy, RF; Fox, E; Ivy, P; Adamson, PC,期刊:Journal of clinical oncology, 页码:3979-3986 , 文章类型: Article,,卷期:2010年28-25]
- Purpose To assess the role of the recombinant bacterial enzyme, glucarpidase (carboxypeptidase-G(2)), leucovorin, and thymidine in the management and outcome of patients with high-dose methotrexate (HDMTX)-induced nephro...
- Phase II Trial of Anastrozole Plus Goserelin in the Treatment of Hormone Receptor-Positive, Metastatic Carcinoma of the Breast in Premenopausal Women
[作者:Carlson, RW; Theriault, R; Schurman, CM; Rivera, E; Chung, CT; Phan, SC; Arun, B; Dice, K; Chiv, VY; Green, M; Valero, V,期刊:Journal of clinical oncology, 页码:3917-3921 , 文章类型: Article,,卷期:2010年28-25]
- Purpose To explore the antitumor activity of the aromatase inhibitor, anastrozole, in the treatment of premenopausal women with hormone receptor-positive, metastatic breast cancer who have been rendered functionally post...
- Relationship Between Tumor Gene Expression and Recurrence in Four Independent Studies of Patients With Stage II/III Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant Fluorouracil Plus Leucovorin
[作者:O'Connell, MJ; Lavery, I; Yothers, G; Paik, S; Clark-Langone, KM; Lopatin, M; Watson, D; Baehner, FL; Shak, S; Baker, J; Cowens, JW; Wolmark, N,期刊:Journal of clinical oncology, 页码:3937-3944 , 文章类型: Article,,卷期:2010年28-25]
- Purpose These studies were conducted to determine the relationship between quantitative tumor gene expression and risk of cancer recurrence in patients with stage II or III colon cancer treated with surgery alone or surg...
- Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation
[作者:Cardinale, D; Colombo, A; Torrisi, R; Sandri, MT; Civelli, M; Salvatici, M; Lamantia, G; Colombo, N; Cortinovis, S; Dessanai, MA; Nole, F; Veglia, F; Cipolla, CM,期刊:Journal of clinical oncology, 页码:3910-3916 , 文章类型: Article,,卷期:2010年28-25]
- Purpose Treatment of breast cancer with trastuzumab is complicated by cardiotoxicity in up to 34% of the patients. In most patients, trastuzumab-induced cardiotoxicity (TIC) is reversible: left ventricular ejection fract...
- Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder Cancer
[作者:Apolo, AB; Riches, J; Schoder, H; Akin, O; Trout, A; Milowsky, MI; Bajorin, DF,期刊:Journal of clinical oncology, 页码:3973-3978 , 文章类型: Proceedings Paper,,卷期:2010年28-25]
- Purpose Fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET)/computed tomography (CT) has been approved for imaging in many malignancies but not for bladder cancer. This study investigated the ...
- Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting
[作者:Thomas, MB; Jaffe, D; Choti, MM; Belghiti, J; Curley, S; Fong, YM; Gores, G; Kerlan, R; Merle, P; O'Neil, B; Poon, R; Schwartz, L; Tepper, J; Yao, F; Haller, D; Mooney, M; Venook, A,期刊:Journal of clinical oncology, 页码:3994-4005 , 文章类型: Article,,卷期:2010年28-25]
- Hepatocelluar carcinoma (HCC) is the most common primary malignancy of the liver in adults and the third most common cause of cancer death worldwide. The incidence of HCC in the United States is rising steadily because o...
- Vinblastine in Children and Adolescents With High-Risk Anaplastic Large-Cell Lymphoma: Results of the Randomized ALCL99-Vinblastine Trial
[作者:Le Deley, MC; Rosolen, A; Williams, DM; Horibe, K; Wrobel, G; Attarbaschi, A; Zsiros, J; Uyttebroeck, A; Marky, IM; Lamant, L; Woessmann, W; Pillon, M; Hobson, R; Mauguen, A; Reiter, A; Brugieres, L,期刊:Journal of clinical oncology, 页码:3987-3993 , 文章类型: Article,,卷期:2010年28-25]
- Purpose The impact of adding vinblastine to a 4-month chemotherapy regimen, based on the Non-Hodgkin's Lymphoma Berlin-Frankfurt-Munster 90 protocol, in childhood high-risk anaplastic large-cell lymphoma (ALCL) was asses...
|